Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2021

View Archived Issues

IL-27 drives metabolic programs and its targeting aids in the treatment of obesity

FBXO22 sensitizes tumor cells to DNA damage by PD-L1 degrading

Novel syngeneic bladder cancer model using organoid line with specific gene deletions

Ube Industries patents integrin alphav antagonists

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

Glixogen Therapeutics identifies GLI1 inhibitors

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents SOS1 inhibitors

Shanghai Zheye Biotechnology divulges new SGLT-1 inhibitors

RAGE-229 inhibits RAGE-DIAPH1 binding and lessens diabetic complications in mice

[68Ga]SP-94 shows excellent uptake in GRP78-positive HCC tumors

GP73 analysis aids in the diagnosis of NASH and staging of hepatic fibrosis

Targeting TWEAK shows potential as alternative therapeutic strategy for psoriasis

Oragenics reports on SARS-CoV-2 vaccine formulations in hamster challenge study

MALT1 mutant mice reveal role of E3 ligase TRAF6 in peripheral immune tolerance

Stepwise engineered IL-37-Fc-fusion protein shows improved therapeutic likeness

Small molecule allows targeted degradation of repeat expansion in vitro and in vivo in ALS models

Chimeric obtains option to license CORE-NK platform from Case Western Reserve University

DREADD approach calms neuropsychiatric dread circuits in primates

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...